Evidence Review Open Access
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Sep 25, 2021; 10(5): 209-216
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.209
Human papillomavirus infection and gastric cancer risk: A meta-epidemiological review
Jong-Myon Bae
Jong-Myon Bae, Department of Preventive Medicine, Jeju National University College of Medicine, Jeju-si 63243, Jeju Province, South Korea
ORCID number: Jong-Myon Bae (0000-0003-3080-7852).
Author contributions: Bae JM performed the literature review, conducted the statistical analysis, and wrote the paper.
Conflict-of-interest statement: The author declares no conflict of interests and no funding sources for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jong-Myon Bae, MD, PhD, Professor, Department of Preventive Medicine, Jeju National University College of Medicine, 102 Jejudaehak-ro, Jeju-si 63243, Jeju Province, South Korea. jmbae@jejunu.ac.kr
Received: February 16, 2021
Peer-review started: February 16, 2021
First decision: March 17, 2021
Revised: March 26, 2021
Accepted: July 22, 2021
Article in press: July 22, 2021
Published online: September 25, 2021

Abstract

Gastric cancer (GC) is a multifactorial disease, and several modifiable risk factors have been reported. This review summarizes and interprets two previous quantitative systematic reviews evaluating the association between human papillomavirus (HPV) infection and GC risk. The results of two systematic reviews evaluating the same hypothesis showed a statistically significant difference in summary odds ratios and their 95% confidence intervals. Thus, it is necessary to conduct a subgroup analysis of Chinese and non-Chinese studies. Additional meta-analyses that control for heterogeneity are required. Reanalysis showed that all the Chinese studies had statistical significance, whereas the non-national studies did not. The funnel plot asymmetry and Egger's test confirmed publication bias in the Chinese studies. In addition, the proportion of HPV-positive cases in Chinese studies was 1.43 times higher than that in non-Chinese studies and 2.81 times lower in controls. Therefore, the deduced evidence is currently insufficient to conclude that HPV infection is associated with GC risk.

Key Words: Papillomavirus, Stomach neoplasm, Case-control studies, Meta-analysis, Systematic review, Risk factors

Core Tip: Chinese studies showed that human papillomavirus infections increased the risk of gastric cancer; however, non-Chinese studies showed no statistical significance. Therefore, the deduced evidence is currently inadequate to conclude that human papillomavirus infection is associated with gastric cancer risk.



INTRODUCTION

Gastric cancer (GC) is the fifth most common incident cancer according to Global Cancer Statistics 2018[1] and ranks third in absolute years of life lost[2]. GC is a multifactorial disease, and several modifiable risk factors have been reported[3,4].

Infection with Helicobacter pylori or oncogenic viruses has important implications for preventing and managing GC[5]. Helicobacter pylori eradication is one of the reasons behind the steady decline in global GC incidence[6]. Therefore, human papillomavirus (HPV), which is among potential oncoviruses posing GC risk reviewed by Niedźwiedzka-Rystwej et al[7], should be considered to control GC occurrence because HPV vaccines have been used to prevent uterine cervix cancer[8,9].

However, the International Agency for Research on Cancer did not suggest an association between HPV infection and GC risk in a monograph published in 2007[10]. This review summarizes and interprets previous quantitative systematic reviews evaluating the association between HPV infection and GC risk.

PREVIOUS SYSTEMATIC REVIEWS

A PubMed (https://pubmed.ncbi.nlm.nih.gov) search, using "papillomavirus infection" and "stomach neoplasms" as the keywords of the hypothesis, identified two systematic reviews as of December 31, 2020[5,11]. Both selected case-control studies and their results are summarized in Table 1.

Table 1 The summary odds ratio with its 95%CI from two systematic reviews.
Ref.
Search to
Subgroup
Case-control studies
sOR (95%CI)
I2 (%)
Zeng et al[11], 2016Jun 2016All157.39 (3.88-14.1)56.7
Wang et al[5], 2020Apr 2020All141.53 (1.00-2.33)59.8
Chinese51.98 (1.04-3.75)73.7
Non-Chinese91.17 (0.68-2.02)33.4
Tissue112.24 (1.13-4.43)66.5
Serum31.04 (0.75-1.44)0.0
HPV-1682.42 (1.00-5.83)67.5
HPV-1831.08 (0.59-1.99)0.0

Zeng et al[11] reported that in 2016, a total of 15 case-control studies, including 12 studies on Chinese patients, and a meta-analysis showed that HPV infection increased the risk of GC by 7.39 times [95% confidence interval (CI) of summary odds ratio (sOR): 3.88–14.1]. Further, a study by Wang et al[5] published in 2020 selected a total of 14 case-control studies, including five studies on Chinese patients, and the sOR was 1.53 (95%CI: 1.00–2.33).

The results of two systematic reviews evaluating the same hypothesis showed a statistically significant difference in sORs and their 95%CI. These findings can be inferred from the following three reasons. First, there was a difference in selection criteria. Wang et al[5] included three serological studies, in addition to tissue tests. Therefore, it is necessary to limit future research to tissue studies and conduct a meta-analysis again. Second, there was a difference in search databases between the two systematic reviews. Zeng et al[11] and Wang et al[5] selected 12 and five Chinese studies, respectively. Whereas Zeng et al[11] did not report a subgroup analysis, Wang et al[5] showed different subgroup analysis results between Chinese and non-Chinese studies. Therefore, it is necessary to conduct subgroup analyses of Chinese and non-Chinese studies in all selected articles. Finally, potential bias is possible due to heterogeneity. Wang et al[5] found no statistical significance in subgroups with less than 50% of the I-squared value, such as non-Chinese studies, serum studies, and HPV-18 studies (Table 1). Therefore, additional meta-analyses that control for heterogeneity are required.

RE-ANALYSIS OF META-ANALYSIS

Both systematic reviews selected a total of 25 articles. After excluding three serological studies[12-14], three studies had no information on the control group[15-17], and one showed zero HPV positivity in both the case and control groups[18]; hence, 18 articles were selected for reanalysis[19-35].

Table 2 illustrates the information extracted for the reanalysis of each study. Xu et al[25] extracted the results for cardia as well as those for the entire region for use in subgroup analysis by GC site.

Table 2 Extracted information of the 18 selected case-control studies.
Ref.
Year
Nation
Site
Test
Sample
PCa
NCa
PCo
NCo
Sha et al[19]1998ChinaGastricPCRFFPE2738461
Dong et al[20]1999ChinaGastricPCROther1027020
Yu et al[21]1999ChinaGastricPCRFFPE301023101
Zhou et al[22]1999ChinaGastricPCRFFPE1931020
Zhu et al[23]2000ChinaGastricPCRFF1131042
Liao et al[24]2001ChinaGastricISHOther2624228
Xu et al[25]2003ChinaCardiaISHFFPE50241040
Xu et al[25]2003ChinaGastricISHFFPE1111251040
Ma et al[26]2007ChinaGastricPCRFFPE1525238
Ma et al[27]2007ChinaCardiaPCRFFPE3261021
Rong et al[28]2007ChinaCardiaPCRFFPE165219
Wang et al[29]2013ChinaGastricPCRFFPE2072482
Su et al[15]2015ChinaGastricPCROther114015
Anwar et al[30]1995JapanGastricPCRFFPE2328210
Erol et al[31]2009TurkeyGastricPCRFFPE17213373
Cândido et al[32]2013BrazilGastricPCRFFPE4361030
Türkay et al[33]2015TurkeyCardiaPCRFFPE21708
Bozdayi et al[34]2019TurkeyGastricPCROther2033521
Leon et al[35]2019EthiopiaCardiaPCRFF1151056

Figure 1 displays a forest plot showing the results of the reanalysis. The sOR for 18 studies was 5.80 (95%CI: 3.27–10.31), showing statistical significance. While the I-squared value was reduced from 60% in all studies to 0% in 12 Chinese studies, their sOR remained statistically significant at 7.86 (95%CI: 5.19–11.89). However, the sOR for six non-Chinese studies was 1.97 (95%CI: 0.79–4.89), which was not statistically significant. In other words, all Chinese studies showed statistical significance; however, the non-national studies did not. This finding was the same in the subgroup analysis by cardiac tissue, formalin-fixed paraffin-embedded tissue, fresh frozen tissue, and polymerase chain reaction (Table 3).

Figure 1
Figure 1 Forest plot for estimating summary odds ratio. CI: Confidence interval.
Table 3 Subgroup analysis by nationality.


All
Chinese studies
Non-Chinese studies
All5.80 (3.27-10.31) [60.0] <18>7.86 (5.19-11.89) [0.0] <12>1.97 (0.79-4.89) [56.8] <6>
Area
Gastric4.83 (2.64-8.83) [62.4] <14>7.08 (4.60-10.89) [0.0] <10>1.54 (0.60-3.92) [62.6] <4>
Cardia10.88 (5.42-21,8) [0.0] <5>11.17 (5.34-23.35) [0.0] <3>8.62 (0.88-84.8) [14.2] <2>
Sample
FFPE5.13 (2.55-10.34) [68.4] <12> 8.02 (4.74-13.6) [19.6] <8>1.38 (0.45-4.16) [58.5] <4>
FF27.9 (3.70-211.7) <2>31.0 (1.76-546.6) <1>25.2 (1.45-439.1) <1>
Methods
PCR5.88 (3.00-11.52) [62.2] <16>10.93 (6.44-18.5) [0.0] <10>1.97 (0.79-4.98) [56.8] <6>
ISH6.23 (1.56-24.9) [64.0] <2>6.23 (1.56-24.9) [64.0] <2>-

Twelve Chinese studies were examined for publication bias. The asymmetry of the funnel plot (Figure 2) and Egger's test (P = 0.013) confirmed publication bias. The trimming sOR from trim-and-fill analysis[36] was 6.78 (95%CI: 4.40–10.45).

Figure 2
Figure 2 Funnel plot in 12 Chinese studies (P value of Egger test = 0.013).
CONCLUSION

To summarize the above reanalysis results, Chinese studies demonstrated that HPV infections increased the risk of GC; nonetheless, non-Chinese studies showed no statistical significance. Therefore, the deduced evidence is currently insufficient to conclude that HPV infection is associated with GC risk.

The following interpretations and suggestions may be made based on the significant associations observed only in Chinese studies. First, there is a possibility that publication bias was involved in the selection of Chinese studies. After checking for publication bias using the funnel plot (Figure 2) and Egger's test, trim-and-fill analysis was performed. However, the trimming sOR in Chinese studies showed that HPV infections persistently increased the risk of GC. This mandated an alternative interpretation. The author attempted to infer that HPV positivity might have been different between Chinese and non-Chinese studies.

Using the information in Table 2, the proportion (%) of HPV positivity (PP) was obtained from both Chinese and non-Chinese studies (Table 4). On combining both the case and control groups, the PPs in Chinese and non-Chinese studies were 27.3% (95%CI: 24.9–29.9) and 24.9% (95%CI: 21.2–28.8), respectively. Their 95%CIs overlapped, showing no statistically significant differences. However, the case-group PP in Chinese studies was 41.9% (95%CI: 38.2–45.6), higher than that in non-Chinese studies (29.3%;95%CI: 23.8–35.2), and their 95%CIs did not overlap, showing a statistically significant difference. In contrast, the control-group PP in Chinese studies was 7.2 % (95%CI: 5.1–9.8), lower than the 20.2 % (95%CI: 15.4–25.7) in non-Chinese studies, and their 95%CIs did not overlap. In other words, the case PP in Chinese studies was 1.43 times (= 41.9/29.3) higher than that in non-Chinese studies and 2.81 times (= 20.2/7.2) lower in controls. This indicates a potentially significant relationship between HPV infection and GC risk in Chinese studies.

Table 4 Proportion of human papillomavirus positivity (%) by nationality.


Chinese studies
Non-Chinese studies
Total
Positive/Observe335/1225127/511
PP (95%CI)27.3 (24.9-29.9)24.9 (21.2-28.8)
Case
Positive/Observe298/71177/263
PP (95%CI)41.9 (38.2-45.6)29.3 (23.8-35.2)
Control
Positive/Observe37/51450/248
PP (95%CI)7.2 (5.1-9.8)20.2 (15.4-25.7)

Given that the PP in the control group of the Chinese studies was significantly lower, descriptive epidemiological studies on HPV infection in the Chinese population are warranted. It is also necessary to conduct follow-up studies on whether the GC incidence rate due to HPV infection will change in the future due to the HPV vaccination project currently targeted at the Chinese population.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Oncology

Country/Territory of origin: South Korea

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Moradi L S-Editor: Wang JL L-Editor: Filipodia P-Editor: Xing YX

References
1.  Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28752]  [Cited by in F6Publishing: 23962]  [Article Influence: 9584.0]  [Reference Citation Analysis (0)]
2.  Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabé E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castañeda-Orjuela C, Catalá-López F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Søreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524-548.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1803]  [Cited by in F6Publishing: 1571]  [Article Influence: 450.8]  [Reference Citation Analysis (0)]
3.  Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z.   Risk Factors for Gastric Cancer: A Systematic Review Asian Pac J Cancer Prev 2018; 19: 591-603.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 38]  [Reference Citation Analysis (0)]
4.  Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 28]  [Article Influence: 37.0]  [Reference Citation Analysis (0)]
5.  Wang H, Chen XL, Liu K, Bai D, Zhang WH, Chen XZ, Hu JK; SIGES research group. Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies. Clin Transl Gastroenterol. 2020;11:e00201.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
6.  Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239-248.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 339]  [Cited by in F6Publishing: 180]  [Article Influence: 113.0]  [Reference Citation Analysis (0)]
7.  Niedźwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Wołącewicz M, Becht R, Roliński J. The Double-Edged Sword Role of Viruses in Gastric Cancer. Cancers (Basel). 2020;12.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
8.  Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila). 2012;5:18-23.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 137]  [Cited by in F6Publishing: 87]  [Article Influence: 15.2]  [Reference Citation Analysis (0)]
9.  Bucchi D, Stracci F, Buonora N, Masanotti G. Human papillomavirus and gastrointestinal cancer: A review. World J Gastroenterol. 2016;22:7415-7430.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 20]  [Cited by in F6Publishing: 18]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
10.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G. Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases. Onco Targets Ther. 2016;9:7105-7114.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 11]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
12.  Kamangar F, Qiao YL, Schiller JT, Dawsey SM, Fears T, Sun XD, Abnet CC, Zhao P, Taylor PR, Mark SD. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer. 2006;119:579-584.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 50]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
13.  Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, Wacholder S, Clayman B, Viscidi RP. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev. 1998;7:305-313.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 48]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
14.  Van Doornum GJ, Korse CM, Buning-Kager JC, Bonfrer JM, Horenblas S, Taal BG, Dillner J. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer. 2003;88:1095-1100.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 37]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
15.  Su LJ, He F. Analysis of the correlation between human papillomavirus and Epstein-Barr virus infection and upper gastrointestinal tumor patients. Int J Virol. 2015;22:159-161.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Zhang J, Tian XY, Wu XJ, Zong XL, Wu J, Ji JF. [Role of papillomavirus in adenocarcinoma of esophagogastric junction]. Zhonghua Yi Xue Za Zhi. 2010;90:2259-2262.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Roesch-Dietlen F, Cano-Contreras AD, Sánchez-Maza YJ, Espinosa-González JM, Vázquez-Prieto MÁ, Valdés-de la O EJ, Díaz-Roesch F, Carrasco-Arroniz MÁ, Cruz-Palacios A, Grube-Pagola P, Sumoza-Toledo A, Vivanco-Cid H, Mellado-Sánchez G, Meixueiro-Daza A, Silva-Cañetas CS, Carrillo-Toledo MG, Lagunes-Torres R, Amieva-Balmori M, Gómez-Castaño PC, Reyes-Huerta JU, Remes-Troche JM. Frequency of human papillomavirus infection in patients with gastrointestinal cancer. Rev Gastroenterol Mex (Engl Ed). 2018;83:253-258.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 1]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
18.  Yuan XY, Wang MY, Wang XY, Chang AY, Li J. Non-detection of Epstein-Barr virus and Human Papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas. Genet Mol Biol. 2013;36:183-184.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 9]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
19.  Sha Q, Cheng HZ, Xie XY. Detection of HPV16,18 in gastric adeno¬carcinoma and adjacent tissues and its clinical significance. Zhonghua Xiaohua Zazhi. 1998;18:320.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Dong WG, Yu JP, Luo HS. Relationship between human papillomavirus infection and the development of gastric carcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:50-52.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Yu JP, Deng T, Yu HG. Study on association of human papillomavirus type 16 with gastric carcinoma. Zhonghua Xiaohua Neijing Zazhi. 1999;16:29-31.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Zhou Y, Ye WT, Wu LD. Research of the relationship between HPV 16 infection and gastric cancer. Shijie Huaren Xiaohua Zazhi. 1999;7:168-169.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Zhu GB, Zhang LF, Cheng J. Association of human papillomavirus 16 and its serum antibody in gastric carcinoma. Zhonghua Putong Waike Zazhi. 2000;15:50-52.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Liao ZL, Wei YJ, Yang YC. Researches on HPV E6 (16, 18), p53, p21WAF1 gene protein expression in gastric cancer tissues. Guangxi Yike Daxue Xuebao. 2001;18:489-490.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Xu WG, Zhang LJ, Lu ZM, Li JY, Ke Y, Xu GW. [Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract]. Zhonghua Yi Xue Za Zhi. 2003;83:1910-1914.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Ma TY, Liu WK, Chu YL, Jiang XY, An Y, Zhang MP, Zheng JW. Detection of human papillomavirus type 16 DNA in formalin-fixed, paraffin-embedded tissue specimens of gastric carcinoma. Eur J Gastroenterol Hepatol. 2007;19:1090-1096.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 4]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
27.  Ma YQ, Pu HW, Chen ZL. Biopathological significance of the abnor¬mal expression of HPV16/18, p53 in cardiac cancer tissues in Xinjiang. Xinjiang Yike Daxue Xuebao. 2007;30:955-957.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Rong XS, Chen J, Li M. A study of the relationship between Human papilloma virus and gastric cardia cancer. Nanjing Daxue Xue Bao. 2007;27:1023-1024.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Wang ZJ, Zhang YQ, Zhang YT. Analysis of relationship of the infection of human papillomavirus 16 H. pylori cagA gene and ureA gene in gastric carcinogenesis. J Pract Med Tech. 2013;20:1061-1064.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Anwar K, Nakakuki K, Imai H, Inuzuka M. Infection of human papillomavirus (hpv) and epstein-barr-virus (ebv) and p53 overexpression in human gastric-carcinoma. Int J Oncol. 1995;7:391-397.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
31.  Erol D, Bulut Y, Yüce H, Ozercan IH. [Investigation of the presence of human papillomavirus DNA in various gastrointestinal carcinoma samples]. Mikrobiyol Bul. 2009;43:259-268.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Cândido AC, de Lima Filho JL, Martins DB, Mendes CM, Vieira JR, Ferraz AA. Association of human papillomavirus genomic sequences by polymerase chain reaction in gastric carcinomas in Brazil. Anal Quant Cytopathol Histpathol. 2013;35:1-6.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Türkay DÖ, Vural Ç, Sayan M, Gürbüz Y. Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature. Pathol Res Pract. 2016;212:77-82.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 10]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
34.  Bozdayi G, Dinc B, Avcikucuk H, Turhan N, Altay-Kocak A, Ozkan S, Ozin Y, Bostanci B. Is Human Papillomavirus and Helicobacter pylori Related in Gastric Lesions? Clin Lab. 2019;65.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 2]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
35.  Leon ME, Kassa E, Bane A, Gemechu T, Tilahun Y, Endalafer N, McKay-Chopin S, Brancaccio RN, Ferro G, Assefa M, Ward E, Tommasino M, Aseffa A, Schüz J, Jemal A, Gheit T. Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia. Infect Agent Cancer. 2019;14:19.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 3]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
36.  Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6281]  [Cited by in F6Publishing: 2066]  [Article Influence: 299.1]  [Reference Citation Analysis (0)]